Page 15 - Service Testing News Today

By Chris Wack Avenue Therapeutics shares were up 68% to 29 cents after the company reached final agreement with the U.S. Food and Drug Administration on the...

By Denny Jacob Adicet Bio shares surged 25%, to $2.21, following bullish commentary from the clinical stage biotechnology company on its outlook. The stock...

By Ben Glickman AlloVir will cut about 95% of its current employee base after scrapping three late-stage clinical trials. The cell-therapy developer said in...

By Colin Kellaher Shares of Dyne Therapeutics took flight in premarket trading Wednesday after the clinical-stage muscle-disease company reported positive...

By Colin Kellaher Intensity Therapeutics has received U.S. Food and Drug Administration approval to launch a Phase 3 study of its lead drug candidate...

By Ben Glickman Shares of Soligenix were higher Tuesday after a trial of the company's vaccine candidate showed protection against two viruses. The stock was...

By Chris Wack Atai Life Sciences saw positive results from its Phase 1 study evaluating orally administered EMP-01. The goals of this Phase 1 study were to...

Health-care companies rose as traders rotated back to the sector from more cyclical niches of the market. Shares of obesity drug maker Novo Nordisk rose to...

By Josh Beckerman Iovance Biotherapeutics shares were recently up 17% following a 19% decline on Wednesday after the company reported a clinical hold in a...

By Adriano Marchese NKGen Biotech said Wednesday it has received regulatory clearance to begin trials for its cell therapy to treat patients with moderate...